BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19913544)

  • 1. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse.
    Cupesi M; Yoshioka J; Gannon J; Kudinova A; Stewart CL; Lammerding J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1290-7. PubMed ID: 19913544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in lamin A/C sensitizes the myocardium to exercise-induced mechanical stress but has no effect on skeletal muscles in mouse.
    Cattin ME; Ferry A; Vignaud A; Mougenot N; Jacquet A; Wahbi K; Bertrand AT; Bonne G
    Neuromuscul Disord; 2016 Aug; 26(8):490-9. PubMed ID: 27287550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.
    Muchir A; Shan J; Bonne G; Lehnart SE; Worman HJ
    Hum Mol Genet; 2009 Jan; 18(2):241-7. PubMed ID: 18927124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nesprin-1 and actin contribute to nuclear and cytoskeletal defects in lamin A/C-deficient cardiomyopathy.
    Nikolova-Krstevski V; Leimena C; Xiao XH; Kesteven S; Tan JC; Yeo LS; Yu ZY; Zhang Q; Carlton A; Head S; Shanahan C; Feneley MP; Fatkin D
    J Mol Cell Cardiol; 2011 Mar; 50(3):479-86. PubMed ID: 21156181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural pathology of the nuclear envelope in familial lamin A/C cardiomyopathy.
    Diercks GF; van Tintelen JP; Tio RA; Kerstjens-Frederikse WS; Pinto YM; Suurmeijer AJ
    Cardiovasc Pathol; 2010; 19(4):e135-6. PubMed ID: 19375354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth.
    Owens DJ; Messéant J; Moog S; Viggars M; Ferry A; Mamchaoui K; Lacène E; Roméro N; Brull A; Bonne G; Butler-Browne G; Coirault C
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
    Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
    Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
    Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
    J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the LMNA gene encoding lamin A/C.
    Genschel J; Schmidt HH
    Hum Mutat; 2000 Dec; 16(6):451-9. PubMed ID: 11102973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of extracellular signal-regulated kinase 1 in mice with cardiomyopathy caused by lamin A/C gene mutation partially prevents pathology before isoenzyme activation.
    Wu W; Iwata S; Homma S; Worman HJ; Muchir A
    Hum Mol Genet; 2014 Jan; 23(1):1-11. PubMed ID: 23933734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
    Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
    J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.
    Arbustini E; Pilotto A; Repetto A; Grasso M; Negri A; Diegoli M; Campana C; Scelsi L; Baldini E; Gavazzi A; Tavazzi L
    J Am Coll Cardiol; 2002 Mar; 39(6):981-90. PubMed ID: 11897440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.